Halozyme Therapeutics Inc (HALO)
59.18
-1.25
(-2.07%)
USD |
NASDAQ |
Oct 04, 16:00
59.21
+0.03
(+0.05%)
After-Hours: 20:00
Halozyme Therapeutics Long Term Notes Receivable (Quarterly)
Long Term Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Long Term Notes Receivable (Quarterly) Data
Date | Value |
---|
Non-current Note Receivables Definition
Non-current Note Receivables are the written obligations the creditors receive from the debtors in exchange for funds that are not due within the next twelve months. It is part of a company’s long term assets.
Long Term Notes Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Long Term Notes Receivable (Quarterly) Benchmarks
Moderna Inc | -- |
Azenta Inc | -- |
Neurocrine Biosciences Inc | -- |
Insulet Corp | -- |
Myomo Inc | -- |